Experimental calcification of the aorta in rabbits: Effects of chelating agents and glucagon

Scandinavian Journal of Laboratory Animal Science

Volumn 31, Issue 4, 2004, Pages 215-219

  Cavallotti, Carlo ^a   Tranquilli, F M ^a   Artico, M ^a   D'Andrea, V ^a   Malinovska, V ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UTEE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM CHELATING AGENT; DIHYDROTACHYSTEROL; EDETIC ACID; EOSIN; GLUCAGON; HEMATOXYLIN; HYDROXYLAMINE; LIPID; TOLONIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; AORTA WALL; ARTERY CALCIFICATION; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HISTOPATHOLOGY; LIPID STORAGE; MALE; NONHUMAN; PHOTOMETER; QUANTITATIVE ANALYSIS; RABBIT; SINGLE DRUG DOSE; STAINING; STATISTICAL ANALYSIS; THORACIC AORTA;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 12344298156     PISSN: 09013393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Andel M, V Brodan & E Kuhn: Relation of glucagon dose and some lipid parameters and glycemia in healthy subjects. Cas Lek Ces. 1980, 119, 616-621.
2. Anderson TJ, J Hubacek, DG Wyse & ML Knudtson: Effect of chelation therapy on endothelial function in patients with coronary artery disease: PATCH substudy. J. Am. Coll. Cardiol. 2003, 41, 420-25.
3. Caren R & L Corbo: Transfer of plasma lipid to platelets by action of glucagon. Metabolism. 1970, 19, 598-607, 1970.
4. Chappel LT & JP Stahl: The correlation between EDTA chelation therapy and improvement in cardiovascular function: a meta-analysis. J.Adv.Med. 1993, 6, 139-160.
5. Chappel LT, R Miranda, M Rubin, JP Carter & J Trowbridge: Chelation therapy. Circulation. 1995, 92, 1350-1351.
6. Cranton EM & JP Frackelton: Free radical pathology in age associated diseases: treatment with EDTA chelation, nutrition and antioxidants. J. Hol. Med. 1984, 6, 6-37.
7. Davis SN & DK Granner: Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas. In Hardman J.G., Limbird L.E. (eds.): Goodman and Gilman's The pharmacological basis of therapeutics, 9th edition. New York, Me Graw-Hill, 1996, pp. 1487-1517.
8. Lamas GA & A Ackermann: Clinical evaluation of chelation therapy: is there any wheat amid the chaff? Am. Heart J. 2000, 140, 4-5.
9. Laslett L: Did you know'? Chelation therapy: new proof of lack of efficacy. Prev. Cardiol. Spring;, 2002, 92-3.
10. Malinovska V, M Artico, S De Santis, F Intrieri, V D'Andrea, I Malinovska & C Cavallotti: Experimental effects of glucagon on some lipidic parameters in humans. Artery. 1998, 11, 603-611.
11. Manuale dei Metodi Quantimet 500 Leica: Microsystems Imaging Solutions Clifton Road Cambridge UK. Ed.: 1997, 1-176.
12. Olszewer E, FC Sabbag & JA Carter: A pilot double-blind study of sodium-magnesium EDTA in peripheral vascular disease. J. Natl. Med. Assoc. 1990, 82, 173-177.
13. Serio A: Appunti dalle lezioni di statistica sanitaria. Kappa Editors, Rome, 1985, 1-238.
14. Sheetz WJ & HS Jager: Receptor-linked proteolysis of membrane-bound glucagons yields a membrane-associated hormone fragments. J. Biol: Chem. 1988, 263, 8509-8514.
15. van Rij AYW, C Salomon, SGK Packer & WG Hopkins: Chelation therapy for intermittent claudication. A double-blind, randomized controlled trial. Circulation. 1994, 90, 1194-1199.
16. Villarruz MV, A Dans & F Tan: Chelation therapy for atherosclerotic cardiovascular disease. Cochrane Database Syst. Rev. 2002, CDO02785.
17. Zamir O, MS Nussbaum, CK Ogle, T Higashlguchi, JF Rafferly & JE Fischer: Addition of glucogon to lipid free total parenteral nutrition reduces production of prostaglandin E2 by stimulated splenic macrophages. J. Parenteral Nutrition. 1993, 17, 226-230.
18. Zechmeist A: A new selective method for the demonstration on calcium using N, N-aph-taloylhydroxyl amine. Histochem. 1979, 61, 223-232.